BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7841251)

  • 1. An outbreak of measles in a highly immunised population: immunisation status and vaccine efficacy.
    Herceg A; Passaris I; Mead C
    Aust J Public Health; 1994 Sep; 18(3):249-52. PubMed ID: 7841251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reasons for non-uptake of measles, mumps, and rubella catch up immunisation in a measles epidemic and side effects of the vaccine.
    Roberts RJ; Sandifer QD; Evans MR; Nolan-Farrell MZ; Davis PM
    BMJ; 1995 Jun; 310(6995):1629-32. PubMed ID: 7795447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of a community outbreak of measles which started in a poorly immunised high school population.
    Merianos A; Miller NC; Patel MS
    Aust J Public Health; 1993 Sep; 17(3):231-6. PubMed ID: 8286496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles immunity and immunisation status in Australian children 1 to 4 years of age.
    Hogg GG; Darlington RJ; Hogg KG; Lester R
    J Paediatr Child Health; 2006 Apr; 42(4):165-9. PubMed ID: 16630315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does primary immunisation status predict MMR uptake?
    Pearce A; Elliman D; Law C; Bedford H;
    Arch Dis Child; 2009 Jan; 94(1):49-51. PubMed ID: 18463124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reported measles immunisation and serological immunity in children attending general practitioners.
    Barrand J; Chapman J; Jeffs DA; Jack I; Wenzel WA; Bridges-Webb C; Levy MH
    Aust J Public Health; 1991 Jun; 15(2):101-6. PubMed ID: 1912051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries.
    Aaby P; Samb B; Simondon F; Seck AM; Knudsen K; Whittle H
    BMJ; 1995 Aug; 311(7003):481-5. PubMed ID: 7647643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An outbreak of measles in the Hunter area of New South Wales.
    Miles TA; Merrell WH
    Aust J Public Health; 1992 Sep; 16(3):302-4. PubMed ID: 1482724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint and limb symptoms in children after immunisation with measles, mumps, and rubella vaccine.
    Benjamin CM; Chew GC; Silman AJ
    BMJ; 1992 Apr; 304(6834):1075-8. PubMed ID: 1586818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased protections during a measles outbreak of children previously vaccinated with a second dose of measles-mumps-rubella vaccine.
    Vitek CR; Aduddell M; Brinton MJ; Hoffman RE; Redd SC
    Pediatr Infect Dis J; 1999 Jul; 18(7):620-3. PubMed ID: 10440438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles, immunisation and disease: rapid epidemiological assessment in two trans-Yamuna villages of Delhi.
    Chaturvedi S; Aggarwal OP
    J Indian Med Assoc; 2000 Jul; 98(7):381-3. PubMed ID: 11143858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The measles/rubella immunisation campaign in Scotland.
    Skinner R; Christie P; Cowden JM
    Health Bull (Edinb); 1996 Jan; 54(1):88-98. PubMed ID: 8820234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A population-based survey of immunisation coverage in two-year-old children.
    Herceg A; Daley C; Schubert P; Hall R; Longbottom H
    Aust J Public Health; 1995 Oct; 19(5):465-70. PubMed ID: 8713195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 16. Childhood immunisation: factors associated with failure to complete the recommended schedule by two years of age.
    Hanna JN; Wakefield JE; Doolan CJ; Messner JL
    Aust J Public Health; 1994 Mar; 18(1):15-21. PubMed ID: 8068786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunisation state and its documentation in hospital patients.
    Ferson MJ
    Arch Dis Child; 1990 Jul; 65(7):763-7. PubMed ID: 2386382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in managing a school-based measles outbreak in Melbourne, Australia, 2014.
    Gibney KB; Brahmi A; O'Hara M; Morey R; Franklin L
    Aust N Z J Public Health; 2017 Feb; 41(1):80-84. PubMed ID: 27960246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles outbreak, Netherlands.
    Wkly Epidemiol Rec; 2000 Apr; 75(15):119-21. PubMed ID: 10795173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.